Free Trial

Coya Therapeutics (COYA) SEC Filings & 10K Form

Coya Therapeutics logo
$6.10 -0.44 (-6.73%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$5.90 -0.21 (-3.36%)
As of 08:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Coya Therapeutics SEC Filings

DateFilerForm TypeView
03/18/2025
7:26 AM
Coya Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2025
7:20 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
7:35 AM
Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
01/13/2025
7:00 AM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
Swaminathan Arun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:00 AM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:30 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:31 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
11/29/2024
3:15 PM
Coya Therapeutics (Filer)
Form 424B3
11/20/2024
4:15 PM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
5:08 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
2:37 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/06/2024
7:06 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:02 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:02 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:27 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:42 AM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:42 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:08 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
8:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:04 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:13 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
5:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
4:31 PM
Coya Therapeutics (Filer)
Form 424B3
06/23/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
06/05/2024
7:00 PM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 PM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:20 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
05/08/2024
4:21 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:COYA) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners